INTRODUCTION:
Malignant skin diseases are on the rise. A review of the scientific literature reveals only a few case reports documenting the development of malignant lesions triggered by tattoos. Given an estimated 10 % prevalence of tattooed individuals in Europe, an increase in tattoo-associated skin tumors is likely to occur in coming years.
MATERIAL AND METHODS:
All patient cases of post-tattoo skin malignancies -including squamous cell carcinoma (SCC), basal cell carcinoma, and malignant melanoma -were analysed (source: Pubmed / all publications up to March 2017). Parameters assessed included composition of tattoo ink, site of tattoo placement, personal or family history of skin cancer, type of skin cancer diagnosed, and time interval from tattooing to diagnosis.
RESULTS:
Pubmed search located 51 publications about tattoo associated skin cancer with a total of 63 cases in these reports. Furthermore, one new unpublished case report with SCC-formation after tattooing is presented -finally summing up to 64 cases. Usage of black and dark blue inks was associated with 58 % of all skin cancers after tattooing. Usage of red ink was associated with 34 % of all skin cancers after tattooing -including 60 % of all SCCs and 73 % of keratoacanthomas. Furthermore obvious differences in time interval between tattooing and first diagnosis of skin cancer were detected for each kind of skin cancer.
CONCLUSION:
Overall, there is a certain risk for skin malignancies due to tattooing, which cannot be neglected. Black, dark blue, and in particular red inks are associated with the occurrence of malignant skin lesions after tattooing. A more in-depth review of the link between tattoo ink and malignant transformation is strongly recommended by the authors.
ESTIMATION OF HEALTH CARE SYSTEM COSTS IN TREATING NON MELANOMA SKIN CANCER
Cozma Cristina-Nicoleta, Raducu Laura, Avino Adelaida, Sinescu Ruxandra Diana, Jecan Radu-Cristian, ROMANIA
INTRODUCTION:
Non melanoma skin cancer is the most common type of cancer, with an increased incidence over the past years. Presently, every year are diagnosed globally between 2 and 3 million of non melanoma skin cancers, 80% of these are usually basal cell carcinomas and 20% squamous cell carcinoma. Because of the increasing incidence, non melanoma skin cancer became a problem for health care services due to patient lower productivity and treatment costs.
Even though mortality is rare, within 1%, a lot of patients require extensive surgery, being exposed to additional anesthesia risks.
MATERIAL AND METHOD:
The present study is a retrospective study, realized over a 2 year period of time, including 150 patients treated in the Plastic Surgery Department of Emergency Clinical Hospital "Prof. Dr. Agrippa Ionescu". Descriptive data analysis was realized and the costs of each surgery were evaluated considering the necessity of general or local anesthesia, hospitalization days and additional imaging tests.
RESULTS:
Non melanoma skin cancers treated were basal cell carcinoma in 83,3% of cases and squamous cell carcinoma in 16,7 % of cases. Costs were higher in patients with bigger lesions, due to the necessity of general anesthesia required for extensive surgery and longer hospitalization days
